Matches in Nanopublications for { ?s ?p "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP1231536.RAbEpNx5SqCAi0Y_IiTHXaGD3irQXqE02kEzhupQz6QYc130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231536.RAbEpNx5SqCAi0Y_IiTHXaGD3irQXqE02kEzhupQz6QYc130_provenance.
- NP1231537.RAauOFp5bzM3zbtkdHIXySw05hc-YjKzSBvjHpjAVYYiQ130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231537.RAauOFp5bzM3zbtkdHIXySw05hc-YjKzSBvjHpjAVYYiQ130_provenance.
- NP1231548.RAfWcrerLdNnSAQdgTUuVTZ-tb7hLrTb29SJWLxBK5GfA130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231548.RAfWcrerLdNnSAQdgTUuVTZ-tb7hLrTb29SJWLxBK5GfA130_provenance.
- NP1231551.RAXI_hghmXlHdoWZnXEUrCav_OpzKerU4wRXrXmyKfiJ0130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231551.RAXI_hghmXlHdoWZnXEUrCav_OpzKerU4wRXrXmyKfiJ0130_provenance.
- NP1231538.RAqFCcCbk4e-fQ_L60ROfvlBtwr5OfACGQAe5R9grvStQ130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231538.RAqFCcCbk4e-fQ_L60ROfvlBtwr5OfACGQAe5R9grvStQ130_provenance.
- NP1231546.RAl69p14vDzTWmjplvT73zYlhMFoX2Y7IcUTHFc_43U2s130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231546.RAl69p14vDzTWmjplvT73zYlhMFoX2Y7IcUTHFc_43U2s130_provenance.
- NP1231544.RAwk-wnajHOhv2Sx9c9Rx3H2FO6df6MiJ8XxSBXIGhBg0130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231544.RAwk-wnajHOhv2Sx9c9Rx3H2FO6df6MiJ8XxSBXIGhBg0130_provenance.
- NP1231552.RA9VaQisCA3qVoU4WAoKilh3hJDkOtaQyeprhC5mFCpNA130_assertion description "[To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status in primary and metastatic CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231552.RA9VaQisCA3qVoU4WAoKilh3hJDkOtaQyeprhC5mFCpNA130_provenance.